Valuation: Virbac

Market Cap 2.57B 2.89B 2.4B 2.19B 4.12B 278B 4.16B 29.02B 11.24B 142B 10.86B 10.62B 456B P/E 2026 *
14.9x
P/E 2027 * 13.3x
Enterprise Value 2.69B 3.03B 2.51B 2.29B 4.32B 291B 4.36B 30.4B 11.78B 149B 11.37B 11.13B 478B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.59x
Free-Float
49.03%
Yield 2026 *
0.56%
Yield 2027 * 0.67%
1 day+0.49%
1 week+1.48%
Current month-1.12%
1 month-4.50%
3 months-7.09%
6 months-12.25%
Current year-13.85%
1 week 301.5
Extreme 301.5
316
1 month 297
Extreme 297
324
Current year 297
Extreme 297
389.5
1 year 297
Extreme 297
389.5
3 years 249.7
Extreme 249.7
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 01/09/2025
Chief Executive Officer 50 27/09/2024
Chief Operating Officer 64 01/01/2022
Director TitleAgeSince
Chairman 61 01/04/2006
Director/Board Member 68 28/07/2010
Director/Board Member 65 05/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
4/22/24 A Sell

Chief Executive Officer

810 0.0096%
4/22/24 A Sell

Chief Executive Officer

140 0.0017%
4/22/24 A Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
+0.49%+1.48%-4.20%+18.46% 2.89B
-0.51%-3.21%+39.72%+112.80% 1,025B
-1.06%-5.88%+37.26%+64.53% 623B
+1.28%-0.34%+11.36%+77.70% 459B
+0.29%-3.20%+60.90%+40.44% 355B
-0.95%-4.05%+21.60%+39.37% 336B
-1.46%-2.89%+11.84%+24.60% 270B
-1.35%-5.43%-4.69%+8.40% 247B
-1.11%-2.73%+35.61%+51.44% 220B
-1.87%-4.29%+30.65%+94.94% 183B
Average -0.61%-1.56%+24.01%+53.27% 372.11B
Weighted average by Cap. -0.50%-2.11%+30.50%+68.95%

Financials

2026 *2027 *
Net sales 1.55B 1.74B 1.44B 1.32B 2.48B 167B 2.51B 17.48B 6.77B 85.58B 6.54B 6.4B 275B 1.64B 1.85B 1.53B 1.4B 2.64B 178B 2.66B 18.57B 7.2B 90.95B 6.95B 6.8B 292B
Net income 174M 196M 162M 148M 279M 18.82B 282M 1.96B 761M 9.62B 735M 719M 30.87B 194M 218M 181M 165M 311M 20.96B 314M 2.19B 848M 10.72B 819M 801M 34.39B
Net Debt 122M 138M 114M 104M 196M 13.24B 198M 1.38B 536M 6.77B 517M 506M 21.73B 44.72M 50.33M 41.74M 38.04M 71.75M 4.84B 72.42M 505M 196M 2.47B 189M 185M 7.94B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
02/10/26 €308.00 +0.49% 5,533
01/10/26 €306.50 -1.61% 11,691
30/09/26 €311.50 +0.32% 20,087
29/09/26 €310.50 +0.98% 3,503
28/09/26 €307.50 +1.32% 5,029
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
306.50EUR
Average target price
412.75EUR
Spread / Average Target
+34.67%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock